These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 23044382)

  • 21. Immunotherapy of multiple myeloma: the start of a long and tortuous journey.
    Harrison SJ; Cook G; Nibbs RJ; Prince HM
    Expert Rev Anticancer Ther; 2006 Dec; 6(12):1769-85. PubMed ID: 17181491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunotherapy in children: report from the Reisensburg-Symposium October 20-22, 2004 and recent advances.
    Klingebiel T; Bader P; Hollatz G; Koehl U; Lehrnbecher T; Meisel R; Dilloo D
    Klin Padiatr; 2006; 218(6):355-65. PubMed ID: 17080339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mixed immunotherapy and chemotherapy of tumors: modeling, applications and biological interpretations.
    de Pillis LG; Gu W; Radunskaya AE
    J Theor Biol; 2006 Feb; 238(4):841-62. PubMed ID: 16153659
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cancer immunotherapy: new approaches].
    Blay JY; Thomachot MC; Alberti L; Bachelot T; Voorzanger-Rousselot N; Puisieux I; Odin L; Ménétrier-Caux C
    Bull Cancer; 2000 Jan; 87(1):97-106. PubMed ID: 10673638
    [No Abstract]   [Full Text] [Related]  

  • 25. Advances in strategies and methodologies in cancer immunotherapy.
    Lam SS; Zhou F; Hode T; Nordquist RE; Alleruzzo L; Raker J; Chen WR
    Discov Med; 2015 Apr; 19(105):293-301. PubMed ID: 25977192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cancer immunotherapy].
    Vakkila J; Pihkala U
    Duodecim; 1999; 115(7):785-94. PubMed ID: 11859512
    [No Abstract]   [Full Text] [Related]  

  • 27. Future of immunotherapy drug combinations and biomarkers.
    Schmidt C
    J Natl Cancer Inst; 2012 Mar; 104(6):434-9. PubMed ID: 22402694
    [No Abstract]   [Full Text] [Related]  

  • 28. Addressing cancer immunotherapy research in Iran: adoptive cell therapy on the horizon.
    Khatami F; Torabi-Rahvar M; Kiani J; Naderi M; Ahmadbeigi N
    Cytotherapy; 2018 Oct; 20(10):1227-1237. PubMed ID: 30266521
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adjuvants targeting innate and adaptive immunity synergize to enhance tumor immunotherapy.
    Verdeil G; Marquardt K; Surh CD; Sherman LA
    Proc Natl Acad Sci U S A; 2008 Oct; 105(43):16683-8. PubMed ID: 18936481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cancer immunotherapy: a treatment for the masses.
    Blattman JN; Greenberg PD
    Science; 2004 Jul; 305(5681):200-5. PubMed ID: 15247469
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adoptive immunotherapy of cancer with activated lymphocytes and interleukin-2.
    Kradin RL; Kurnick JT
    Pathol Immunopathol Res; 1986; 5(3-5):193-202. PubMed ID: 3299346
    [No Abstract]   [Full Text] [Related]  

  • 32. Cellular and Antibody Based Approaches for Pediatric Cancer Immunotherapy.
    Huang MA; Krishnadas DK; Lucas KG
    J Immunol Res; 2015; 2015():675269. PubMed ID: 26587548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunotherapy for infection and malignancy in children with cancer.
    Frost JD; Sondel PM
    Adv Pediatr; 1994; 41():385-413. PubMed ID: 7992692
    [No Abstract]   [Full Text] [Related]  

  • 34. Melanoma vaccines: possible progress after years of frustration?
    Schmidt C
    J Natl Cancer Inst; 2009 Feb; 101(3):140-1. PubMed ID: 19176461
    [No Abstract]   [Full Text] [Related]  

  • 35. [Immunotherapy for colorectal cancer].
    Tougeron D; Fauquembergue É; Latouche JB
    Bull Cancer; 2013 Sep; 100(9):871-85. PubMed ID: 23917703
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antitumor immunity and cellular cancer therapies].
    Catros-Quemener V; Bouet F; Genetet N
    Med Sci (Paris); 2003 Jan; 19(1):43-53. PubMed ID: 12836191
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CIMT 2014: Next waves in cancer immunotherapy--report on the 12th annual meeting of the Association for Cancer Immunotherapy: May 6–8 2014, Mainz, Germany.
    Diken M; Boegel S; Grunwitz C; Kranz LM; Reuter K; van de Roemer N; Vascotto F; Vormehr M; Kreiter S
    Hum Vaccin Immunother; 2014; 10(10):3090-100. PubMed ID: 25483671
    [No Abstract]   [Full Text] [Related]  

  • 38. Cancer immunotherapy using interleukin-2 and interleukin-2-activated lymphocytes.
    Rosenberg SA; Lotze MT
    Annu Rev Immunol; 1986; 4():681-709. PubMed ID: 3518753
    [No Abstract]   [Full Text] [Related]  

  • 39. [Immunological tumor therapy].
    Dietrich K; Theobald M
    Internist (Berl); 2015 Aug; 56(8):907-16; quiz 917. PubMed ID: 26187335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cancer vaccines.
    Nakamura Y
    Clin Adv Hematol Oncol; 2011 Oct; 9(10):778-9. PubMed ID: 22252581
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.